CAS RN: 3397-23-7

Ornipressin

Product Availability

Choose a grade to view its available package options.

6 package records0 with current stock2 grade groups
Batch No.PackageAvailabilityLead TimeInquiry
Batchno.20260608 5mg Out of stock 5-7 business days Inquiry
Batch No.PackageAvailabilityLead TimeInquiry
Batchno.20250925 100mg Out of stock Inquiry
Batchno.20250208 10mg Out of stock Inquiry
Batchno.20250925 25mg Out of stock Inquiry
Batchno.20251207 50mg Out of stock Inquiry
Batchno.20250723 5mg Out of stock Inquiry
  • Product code: starshine_CAS3397-23-7
  • Purity/Analytical Methods: >99.0%
GET A QUOTE

3397-23-7 / N-[5-amino-1-[(2-amino-2-oxoethyl)amino]-1-oxopentan-2-yl]-1-[19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]pyrrolidine-2-carboxamide

Standard CAS: 3397-23-7 Multi CAS: Yes

Basic Information

CAS
3397-23-7
Multi CAS
Yes
Molecular Formula
C45H63N13O12S2
Molecular Weight
1042.200000
Exact Mass
1041.416057
InChI
InChI=1S/C45H63N13O12S2/c46-16-4-8-28(39(64)51-21-37(50)62)53-44(69)34-9-5-17-58(34)45(70)33-23-72-71-22-27(47)38(63)54-30(19-25-10-12-26(59)13-11-25)42(67)55-31(18-24-6-2-1-3-7-24)41(66)52-29(14-15-35(48)60)40(65)56-32(20-36(49)61)43(68)57-33/h1-3,6-7,10-13,27-34,59H,4-5,8-9,14-23,46-47H2,(H2,48,60)(H2,49,61)(H2,50,62)(H,51,64)(H,52,66)(H,53,69)(H,54,63)(H,55,67)(H,56,65)(H,57,68)/t27-,28-,29-,30-,31-,32-,33-,34-/m0/s1
InChIKey
MUNMIGOEDGHVLE-LGYYRGKSSA-N

Computed Properties

Structural Parameters

Heavy atom count
72
Aromatic heavy atom count
12
Fraction Csp3
0.49
Rotatable bonds
18
H-bond acceptors
16
H-bond donors
13
Molar refractivity
263.9
TPSA
425.55

LogP / Solubility

WLOGP
-4.72
MLOGP
-4.05
XLogP3
-4.2
Consensus LogP
-4.32
Log S (ESOL)
-2.26
Class (ESOL)
Moderately soluble
Log S (Ali)
-4.7
Class (Ali)
Slightly soluble
Log S (SILICOS-IT)
-4.68
Class (SILICOS-IT)
Slightly soluble

ADME

GI absorption
Low
BBB permeant
No
P-gp substrate
Yes
CYP1A2 inhibitor
No
CYP2C19 inhibitor
No
CYP2C9 inhibitor
No
CYP2D6 inhibitor
No
CYP3A4 inhibitor
No
Log Kp (skin permeation)
-12.43

Drug-likeness / Medicinal Chemistry

Lipinski
No
Ghose
No
Veber
No
Egan
No
Muegge
No
Bioavailability score
0.17
Brenk alerts
1
Leadlikeness
No
Synthetic Accessibility
10

Get In Touch

Contact Us